RTP startup Dignify Therapeutics hires its first CEO
02/25/2014 2:50 PM
02/25/2014 2:52 PM
Research Triangle Park startup Dignify Therapeutics has named its first CEO nine months after the company’s founding.
The new chief executive, Benny Ward, 50, is a veteran of the Triangle’s startup scene, having held senior executive positions at a trio of local companies in the past two decades. Before being named CEO, Ward worked as an advisor to Dignify.
Dignify develops treatments that restore bladder control and bowel control to people with spinal injuries and other neurological conditions that cause incontinence. The company is developing DTI-100, a drug that induces the bladder and the bowels to contract.
Dignify has eight employees and is developing three treatment programs, said Karl Thor, a co-founder of Dignify and the company’s president.
Ward’s previous positions include CFO of Closure Medical Corp. and CFO of InnerPulse. Most recently Ward was executive vice president of BioDelivery Sciences International, a Raleigh company specializing in pain and addiction medicine that terminated Ward’s contract without cause in 2012.
Join the Discussion
News & Observer is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere on the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.